JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M503120200 on July 11, 2005

J. Biol. Chem., Vol. 280, Issue 36, 31530-31536, September 9, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
280/36/31530    most recent
M503120200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, C. H.
Right arrow Articles by Pfeffer, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, C. H.
Right arrow Articles by Pfeffer, L. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Interferon Induces NF-{kappa}B-inducing Kinase/Tumor Necrosis Factor Receptor-associated Factor-dependent NF-{kappa}B Activation to Promote Cell Survival*{boxs}

Chuan He Yang, Aruna Murti, and Lawrence M. Pfeffer{ddagger}

From the Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center and the University of Tennessee Cancer Institute, Memphis, Tennessee 38163

Type I interferons (IFNs) play critical roles in the host defense by modulating the expression of various genes via the IFN-dependent activation of signal transducers and activators of transcription and NF-{kappa}B (nuclear factor kappa B) transcription factors. Previous studies established that IFN{alpha}/{beta} activates NF-{kappa}B to promote cell survival through a phosphatidylinositol 3-kinase (PI3K)/Akt pathway, which involves serine phosphorylation and degradation of I{kappa}B{alpha}. We now describe a second pathway by which IFNs activate NF-{kappa}B that is independent of I{kappa}B degradation. This pathway involves NF-{kappa}B-inducing kinase (NIK) and the tumor necrosis factor receptor-associated factor-2 (TRAF2) and results in IFN{alpha}/{beta}-induced processing of the p100/NF-{kappa}B2 precursor into p52. IFN{alpha}/{beta} stimulates NF-{kappa}B DNA binding and NF-{kappa}B-dependent transcription. Whereas expression of NIK and TRAF2 constructs causes NF-{kappa}B activation, expression of dominant negative NIK and TRAF2 constructs blocks IFN-promoted NF-{kappa}B activation and IFN-stimulated {kappa}B-dependent transcription and IFN{alpha}/{beta}-induced processing of the p100/NF-{kappa}B2 precursor into p52. In contrast, PI3K does not mediate IFN{alpha}/{beta}-induced p100 processing, although PI3K is involved in the pathway resulting in I{kappa}B{alpha} degradation. Moreover, whereas IFN promotes cell survival in lymphoblastoid cells, expression of dominant negative NIK and TRAF2 constructs enhances IFN-induced apoptosis. Our results for the first time place NIK and TRAF2, previously shown to function in TNF signaling, within the IFN signal transduction pathway. Thus, IFN induces NF-{kappa}B activation to mediate IFN-dependent cell survival signals through a "canonical" pathway of I{kappa}B{alpha} proteolysis mediated by PI3K/Akt and a "noncanonical" pathway of p100 processing mediated by NIK/TRAF.


Received for publication, March 21, 2005 , and in revised form, July 5, 2005.

* This work was supported by National Institutes of Health Grant CA73753 (to L. M. P.) and by funds from the Muirhead Chair Endowment at the University of Tennessee Health Science Center. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{boxs} The on-line version of this article (available at http://www.jbc.org) contains a supplemental figure.

{ddagger} To whom correspondence should be addressed: Dept. of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, 930 Madison Ave. (Rm. 530), Memphis, TN 38163. Tel.: 901-448-7855; Fax: 901-448-6979: E-mail: lpfeffer{at}utmem.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Ghosh, G. P. Srivastava, D. Xu, L. C. Schulz, and R. M. Roberts
A link between SIN1 (MAPKAP1) and poly(rC) binding protein 2 (PCBP2) in counteracting environmental stress
PNAS, August 19, 2008; 105(33): 11673 - 11678.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. H. Yang, A. Murti, S. R. Pfeffer, M. Fan, Z. Du, and L. M. Pfeffer
The Role of TRAF2 Binding to the Type I Interferon Receptor in Alternative NF{kappa}B Activation and Antiviral Response
J. Biol. Chem., May 23, 2008; 283(21): 14309 - 14316.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Choudhary, M. Lu, R. Cui, and A. R. Brasier
Involvement of a Novel Rac/RhoA Guanosine Triphosphatase-Nuclear Factor-{kappa}B Inducing Kinase Signaling Pathway Mediating Angiotensin II-Induced RelA Transactivation
Mol. Endocrinol., September 1, 2007; 21(9): 2203 - 2217.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Bitko, O. Shulyayeva, B. Mazumder, A. Musiyenko, M. Ramaswamy, D. C. Look, and S. Barik
Nonstructural Proteins of Respiratory Syncytial Virus Suppress Premature Apoptosis by an NF-{kappa}B-Dependent, Interferon-Independent Mechanism and Facilitate Virus Growth
J. Virol., February 15, 2007; 81(4): 1786 - 1795.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Gustin, C. K. Korgaonkar, R. Pincheira, Q. Li, and D. B. Donner
Akt Regulates Basal and Induced Processing of NF-{kappa}B2 (p100) to p52
J. Biol. Chem., June 16, 2006; 281(24): 16473 - 16481.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. A. James, J. H. Lee, and A. J. Klingelhutz
Human Papillomavirus Type 16 E6 Activates NF-{kappa}B, Induces cIAP-2 Expression, and Protects against Apoptosis in a PDZ Binding Motif-Dependent Manner.
J. Virol., June 1, 2006; 80(11): 5301 - 5307.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.